Leonard S. Schleifer, Bd. Co-Chair, President & CEO at REGENERON PHARMACEUTICALS, INC. (REGN), sold 45,660 shares at $979.22 ($44.7M) on 2024-05-17, disclosed to the SEC on 2024-05-17.
Scheduled sale ($44.7M) by Bd. Co-Chair, President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $979.22 | 22,687 | $22.2M | 49.7% |
| 2 | $979.22 | 22,687 | $22.2M | 49.7% |
| 3 | $980.07 | 143 | $140K | 0.3% |
| 4 | $980.07 | 143 | $140K | 0.3% |
| Total | $979.23 avg | 45,660 | $44.7M | 100% |
| Filing → |
| REGN | SELL | 2024-05-15 | $70.1M | — | Filing → |
| REGN | SELL | 2022-04-07 | $10.1M | — | Filing → |
| REGN | SELL | 2022-04-04 | $4.1M | — | Filing → |